[ad_1]
The U.S.-listed shares of China-based companies took a broad hit Monday after data showed that China’s economy grew at a weaker rate than expected in the second quarter and as the odds of another Trump presidency increase.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...